These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 3369432

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S, Mick R, Xu F, Stonys E, Le Beau MM, Larson R, Vardiman JW.
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings.
    Parlier V, van Melle G, Beris P, Schmidt PM, Tobler A, Haller E, Bellomo MJ.
    Cancer Genet Cytogenet; 1994 Dec; 78(2):219-31. PubMed ID: 7828157
    [Abstract] [Full Text] [Related]

  • 9. Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases.
    Foucar K, Langdon RM, Armitage JO, Olson DB, Carroll TJ.
    Cancer; 1985 Aug 01; 56(3):553-61. PubMed ID: 3891071
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival.
    Bernasconi P, Alessandrino EP, Boni M, Bonfichi M, Morra E, Lazzarino M, Campagnoli C, Astori C.
    Am J Hematol; 1994 Aug 01; 46(4):270-7. PubMed ID: 8037176
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Chromosome abnormalities in myelodysplastic syndrome].
    Fujita K, Mori H, Niikura H, Terada H, Shinohara T.
    Rinsho Byori; 1990 Aug 01; 38(8):911-6. PubMed ID: 2232253
    [Abstract] [Full Text] [Related]

  • 15. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
    Ghaddar HM, Stass SA, Pierce S, Estey EH.
    Leukemia; 1994 Oct 01; 8(10):1649-53. PubMed ID: 7934160
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical and cytogenetic study of chromosome 1 abnormality in myelodysplastic syndrome].
    Wang W, Chen Z, Yu M, Wang H, Lou J, Xu H, Hu C, Mu Q, Tong H, Wei J, Zhou X, Jin J.
    Zhonghua Xue Ye Xue Za Zhi; 2015 Oct 01; 36(10):818-23. PubMed ID: 26477758
    [Abstract] [Full Text] [Related]

  • 20. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia.
    Estey EH, Keating MJ, Dixon DO, Trujillo JM, McCredie KB, Freireich EJ.
    Hematol Pathol; 1987 Oct 01; 1(4):203-8. PubMed ID: 3504436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.